Cambridge, UK 26 September 2006, Lectus Therapeutics Ltd (“Lectus”), the drug discovery and development company focusing on next-generation ion channel modulators, announced today the relocation of its corporate headquarters and research facility to the Babraham Research Campus, Cambridge, UK. Lectus, originally based in Bristol, UK, will run all research operations as well as commercial and financial activities from the new location.
